Rasagiline belongs to which drug category?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Rasagiline belongs to which drug category?

Explanation:
Rasagiline works by inhibiting monoamine oxidase-B in the brain, the enzyme that breaks down dopamine. By blocking this enzyme, it increases the amount of dopamine available in the brain, helping to improve Parkinsonian symptoms. Since it boosts endogenous dopamine rather than directly stimulating dopamine receptors, it’s classified as an indirect-acting dopaminergic drug. This is different from direct-acting dopamine receptor agonists (which bind receptors) and from dopamine precursors like levodopa (which provide more dopamine directly). Some may call it an MAO-B inhibitor, but the functional category used here is indirect-acting dopaminergic.

Rasagiline works by inhibiting monoamine oxidase-B in the brain, the enzyme that breaks down dopamine. By blocking this enzyme, it increases the amount of dopamine available in the brain, helping to improve Parkinsonian symptoms. Since it boosts endogenous dopamine rather than directly stimulating dopamine receptors, it’s classified as an indirect-acting dopaminergic drug. This is different from direct-acting dopamine receptor agonists (which bind receptors) and from dopamine precursors like levodopa (which provide more dopamine directly). Some may call it an MAO-B inhibitor, but the functional category used here is indirect-acting dopaminergic.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy